Category: Products & Treatment

Products & Treatment

FDA Accepts NDA for Apnimed Sleep Apnea Pill

The FDA will review a New Drug Application for Apnimed's AD109, an investigational oral pill for the treatment of adults with obstructive sleep apnea with a target action date of Feb 28, 2027.

Products & Treatment

Ai-Generated Drug Rentosertib Trialed for Idiopathic Pulmonary Fibrosis

Insilico Medicine initiated a Phase 3 clinical trial for Rentosertib, an oral medication discovered using artificial intelligence to treat idiopathic pulmonary fibrosis (IPF).

Products & Treatment

Capnography and Pulse Oximetry in the PICU

For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.

Industry & Regulatory News

Fifth Annual World Bronchiectasis Day Set for July 1

Global organizations unite to raise awareness and improve care for more than 1 million people living with bronchiectasis.

Pharmaceuticals

Same-Day COVID-19 and Flu Vaccines Are Safe for Adults

Research involving 2.5 million patients found no increase in serious adverse events when receiving both COVID-19 and influenza vaccinations during the same visit.

Diagnostics & Testing

High Accuracy for Robotic Lung Biopsy Imaging

The MATCH 2 study reported a 96.7% overall diagnostic yield for peripheral lung nodules when using robotic-assisted bronchoscopy (RAB) with integrated imaging.

Monitoring & Treatment

Remote Monitoring Fails to Reduce Readmissions After Sepsis, LRTI

Remote monitoring did not increase the time spent at home after discharge among patients hospitalized with sepsis or lower respiratory tract infection, according to results from a randomized clinical trial of 1,286 adults.